readthroughSign in
CompanyVTGNNasdaqSouth San Francisco, CA

VistaGen Therapeutics, Inc.

VistaGen Therapeutics develops intranasal pherine product candidates designed to modulate neurocircuitry without systemic absorption.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 13Latest story